Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 971

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 971
---
 Program Assets), and (iii) up to an additional $1,000,000 to be advanced by
Parent upon request of the Company after March 1, 2025 until the Closing Date but disbursed in an amount no greater than $500,000 per calendar month (which, for the avoidance of doubt, will be contingent on Parent’s receipt of proceeds
from the Concurrent Investment and secured by the Program Assets) for any expenses incurred by the Company in the ordinary course of business in connection with the Program Assets, and such amount shall be paid by Parent to the Company no

A-57

later than five (5) Business Days after the request is made (and invoice or proof of expense is provided to Parent) as long as no event of default has occurred and is continuing under this
Agreement as of the date of such request and the so long as the parties hereto are then still working in good faith toward a Closing;

(hh) “” (which can be positive or negative) means the difference of (A) Closing Cash and Cash
Equivalents, (B) the $322,993.56 in prepaid expenses incurred in connection with Master Services Agreement, dated January 17, 2023, by and between the Company and PPD Development, L.P., as supplemented by that certain Project
Addendum, dated February 8, 2023, by and between the Company and PPD Development, L.P., (C) Closing Liabilities and Debt, (D) Unpaid Company Transaction Expenses, in each case determined as of 12:01 A.M.
Eastern Time on the Closing Date in accordance with GAAP and using the policies, conventions, methodologies and procedures used by the Company in preparing the Company Unaudited Financial Statements (to the extent consistent with GAAP). For
illustrative purposes only, of the Company Disclosure Letter sets forth a sample calculation of the Net Working Capital Amount as of September 30, 2024 (as if the Closing Date occurred on such date);

(ii)
“” means a Company Stock Option that is unexpired, unexercised and
outstanding immediately prior to the Effective Time and has a per share exercise price greater than $0.64.

(jj) “” means the representations and warranties of Parent, Merger Sub I and Merger Sub II set forth in ;

(kk) “” means the common stock of Parent, par value $0.001 per share;

(ll) “” means the representations and warranties of Parent